Medicare Enrolled

Dr. Roy Prashad, D.O.

Rheumatology · Riverhead, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
31 MAIN RD, Riverhead, NY 11901
6317270565
In practice since 2005 (20 years)
NPI: 1760473573 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Prashad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Prashad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Prashad

Dr. Roy Prashad is a rheumatology specialist in Riverhead, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Prashad performed 53,534 Medicare services across 2,091 unique beneficiaries.

Between the years covered by Open Payments, Dr. Prashad received a total of $99,536 from 45 pharmaceutical and/or device companies across 827 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Prashad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 7% volume in NY $99,536 industry payments

Medicare Practice Summary

Medicare Utilization ↗
53,534
Medicare services
Top 7% in NY for rheumatology
2,091
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,677 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
30,968 $10 $55
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
12,290 $26 $158
Denosumab injection (Prolia/Xgeva) 6,060 $18 $56
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
937 $110 $259
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
759 $8 $20
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
505 $162 $347
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
337 $4 $26
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
318 $128 $613
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
310 $15 $68
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
274 $27 $430
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
197 $62 $483
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
136 $13 $175
New patient office visit, complex (60-74 min) 97 $199 $498
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
83 $151 $395
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
57 $46 $111
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
54 $72 $120
Injection, methylprednisolone acetate, 40 mg 54 $5 $7
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
44 $70 $180
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
41 $62 $156
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
13 $9 $13
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
81.8% high complexity
13.6% medium
4.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$99,536
Total received (2018-2024)
Avg $14,219/year across 7 years
Top 7% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
827
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$88,981 (89.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,555 (10.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$13,051
2023
$11,444
2022
$20,873
2021
$1,132
2020
$7,179
2019
$26,322
2018
$19,534

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$11,307
Janssen Biotech, Inc.
$637
Amgen Inc.
$253
PFIZER INC.
$181
Lilly USA, LLC
$118
Organon Llc
$90
GlaxoSmithKline, LLC.
$86
AstraZeneca Pharmaceuticals LP
$63
ANI Pharmaceuticals, Inc.
$59
Alexion Pharmaceuticals, Inc.
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Octapharma USA, Inc.
$47
UCB, Inc.
$32
SOBI, INC
$27
Mallinckrodt Hospital Products Inc.
$25
Aurinia Pharma U.S., Inc.
$17
Top 3 companies account for 93.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$40,979
Mallinckrodt Enterprises LLC
$16,688
AbbVie, Inc.
$12,476
Mallinckrodt LLC
$12,120
Mallinckrodt Hospital Products Inc.
$3,051
Horizon Therapeutics plc
$2,347
AbbVie Inc.
$2,126
Janssen Biotech, Inc.
$1,987
Amgen Inc.
$1,565
PFIZER INC.
$1,131
GlaxoSmithKline, LLC.
$714
Lilly USA, LLC
$509
Novartis Pharmaceuticals Corporation
$476
Genentech USA, Inc.
$455
Regeneron Healthcare Solutions, Inc.
$288
Boehringer Ingelheim Pharmaceuticals, Inc.
$243
AstraZeneca Pharmaceuticals LP
$238
ANI Pharmaceuticals, Inc.
$220
UCB, Inc.
$213
Celgene Corporation
$170
Horizon Pharma plc
$151
E.R. Squibb & Sons, L.L.C.
$142
Alexion Pharmaceuticals, Inc.
$124
Aurinia Pharma U.S., Inc.
$92
Radius Health, Inc.
$90
Organon Llc
$90
Flexion Therapeutics, Inc.
$82
DePuy Synthes Sales Inc.
$76
Hikma Pharmaceuticals USA
$73
Abbott Laboratories
$61
Exeltis, USA Inc.
$55
Sobi, Inc
$53
Ferring Pharmaceuticals Inc.
$52
MEDEXUS PHARMA, INC.
$48
Octapharma USA, Inc.
$47
West-Ward Pharmaceuticals
$44
Takeda Pharmaceuticals U.S.A., Inc.
$39
SANOFI-AVENTIS U.S. LLC
$39
MEDAC PHARMA, INC.
$38
Pacira Therapeutics, Inc.
$34
Organon LLC
$29
SOBI, INC
$27
GENZYME CORPORATION
$20
Fresenius Kabi USA, LLC
$20
Ultragenyx Pharmaceutical Inc.
$15
Top 3 companies account for 70.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · HUMIRA · Humira · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · Otezla · PANZYGA · PENNSAID · PURIFIED CORTROPHIN GEL · Proclaim Family of SCS IPGs · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPEVIGO · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for rheumatology in NY.

Looking for a rheumatology specialist in Riverhead?
Compare rheumatologists in the Riverhead area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
13
Per 100K population
0.9
County median income
$128,329
Nearest hospital
PECONIC BAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Prashad is a mixed practice specialist, with above-average Medicare volume (top 7% in NY), with speaking/promotional industry engagement in the top 7% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Prashad experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Prashad performed 30,968 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Prashad receive payments from pharmaceutical companies?
Yes. Dr. Prashad received a total of $99,536 from 45 companies across 827 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Prashad's costs compare to other rheumatologists in Riverhead?
Dr. Prashad's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Prashad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →